Erez Aminov - May 21, 2024 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Chief Executive Officer, Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov
Stock symbol
MIRA
Transactions as of
May 21, 2024
Transactions value $
$8,176
Form type
4
Date filed
5/22/2024, 05:42 PM
Previous filing
Mar 27, 2024
Next filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRA Common Stock Purchase $2K +2K +0.54% $1.00 376K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $1.03K +1K +0.27% $1.03 377K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $510 +500 +0.13% $1.02 377K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $1.68K +2K +0.53% $0.84 379K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $850 +1K +0.26% $0.85 380K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $522 +600 +0.16% $0.87 381K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $808 +800 +0.21% $1.01 381K May 21, 2024 Direct F1
transaction MIRA Common Stock Purchase $776 +800 +0.21% $0.97 382K May 21, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are directly owned by Mr. Aminov.